Your browser doesn't support javascript.
loading
Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021.
Whitaker, Heather J; Elgohari, Suzanne; Rowe, Cathy; Otter, Ashley David; Brooks, Tim; Linley, Ezra; Hayden, Iain; Ribeiro, Sonia; Hewson, Jacqueline; Lakhani, Anissa; Clarke, Eleanor; Tsang, Camille; Campbell, Colin Nj; Ramsay, Mary; Brown, Kevin; Amirthalingam, Gayatri.
Afiliación
  • Whitaker HJ; Statistics, Modelling and Economics Department, National Infection Service, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK. Electronic address: heather.whitaker@phe.gov.uk.
  • Elgohari S; Immunisation and Countermeasures Division, National Infection Service, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Rowe C; Diagnostics and Genomics, National Infection Service, Public Health England, Porton Down, Salisbury SP4 0JG, UK.
  • Otter AD; Diagnostics and Genomics, National Infection Service, Public Health England, Porton Down, Salisbury SP4 0JG, UK.
  • Brooks T; Diagnostics and Genomics, National Infection Service, Public Health England, Porton Down, Salisbury SP4 0JG, UK.
  • Linley E; Vaccine Evaluation Unit, National Infection Service, Public Health England, Manchester M13 9WL, UK.
  • Hayden I; Immunisation and Countermeasures Division, National Infection Service, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Ribeiro S; Immunisation and Countermeasures Division, National Infection Service, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Hewson J; Diagnostics and Genomics, National Infection Service, Public Health England, Porton Down, Salisbury SP4 0JG, UK.
  • Lakhani A; Immunisation and Countermeasures Division, National Infection Service, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Clarke E; Immunisation and Countermeasures Division, National Infection Service, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Tsang C; Immunisation and Countermeasures Division, National Infection Service, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Campbell CN; Immunisation and Countermeasures Division, National Infection Service, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Ramsay M; Immunisation and Countermeasures Division, National Infection Service, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Brown K; Immunisation and Countermeasures Division, National Infection Service, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Amirthalingam G; Immunisation and Countermeasures Division, National Infection Service, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
J Infect ; 83(2): 237-279, 2021 08.
Article en En | MEDLINE | ID: mdl-33989631
ABSTRACT
The COVID-19 vaccination programme commenced in England on 8th December 2020 primarily based on age; by 7th March 2021 approximately 93% of the English population aged 70+ years had received at least 1 dose of either the Pfizer BioNTech or AstraZeneca vaccines. Using a nucleoprotein assay that detects antibodies following natural infection only and a spike assay that detects infection and vaccine-induced responses, we aim to describe the impact of vaccination on SARS-CoV-2 antibody prevalence in English blood donors.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Risk_factors_studies Límite: Aged / Humans País/Región como asunto: Europa Idioma: En Revista: J Infect Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Risk_factors_studies Límite: Aged / Humans País/Región como asunto: Europa Idioma: En Revista: J Infect Año: 2021 Tipo del documento: Article